These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles. Dennis JA, Healy PJ. Res Vet Sci; 1999 Aug; 67(1):1-6. PubMed ID: 10425233 [Abstract] [Full Text] [Related]
12. Amino acids levels and lipid peroxidation in maple syrup urine disease patients. Barschak AG, Sitta A, Deon M, Busanello EN, Coelho DM, Cipriani F, Dutra-Filho CS, Giugliani R, Wajner M, Vargas CR. Clin Biochem; 2009 Apr; 42(6):462-6. PubMed ID: 19121297 [Abstract] [Full Text] [Related]
13. [3 patients with maple syrup urine disease]. Merinero B, del Valle JA, García MJ, García Miguel MJ, Barrio MI, García Hortelano J, Morales E, González F, García Aparicio J, Sáez Pérez E. An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657 [Abstract] [Full Text] [Related]
14. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex. Wajner A, Bürger C, Dutra-Filho CS, Wajner M, de Souza Wyse AT, Wannmacher CM. Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076 [Abstract] [Full Text] [Related]
20. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease. Jouvet P, Jugie M, Rabier D, Desgrès J, Hubert P, Saudubray JM, Man NK. Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125 [Abstract] [Full Text] [Related] Page: [Next] [New Search]